This inventor holds 2 USPTO granted patents. Top assignees: Gsf Forschungszentrum Fur Umwelt Und Geshundheit Gmbh, Gsf-Forschungszentrum Fur Umwelt Und Gesundheit, Gmbh. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- München, DE (2002)
- Munich, DE (2004)
Company Filing History:
1 out of 1 
1 out of 40 Years Active: 2002-2004
Title: Christoph Schuhmacher: Innovator in Cancer Diagnostics and Therapy
Introduction
Christoph Schuhmacher is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer diagnostics and therapy, particularly focusing on gastric carcinoma. With a total of 2 patents, Schuhmacher's work has the potential to impact the medical community profoundly.
Latest Patents
Schuhmacher's latest patents include innovations related to mutations of E-cadherin, which serve as a basis for the diagnosis and therapy of human malignant tumors. One of his inventions describes monoclonal antibodies that are useful for the specific detection and therapy of diffuse gastric carcinoma. Further embodiments of this invention detail therapeutic and diagnostic means for the detection and treatment of diffuse gastric carcinomas, as well as methods for their detection and therapy.
Career Highlights
Throughout his career, Christoph Schuhmacher has worked with esteemed organizations such as the GSF-Forschungszentrum für Umwelt und Gesundheit GmbH. His research has focused on developing innovative solutions for cancer treatment, showcasing his dedication to improving patient outcomes.
Collaborations
Schuhmacher has collaborated with notable colleagues, including Karl-Friedrich Becker and Manfred Eulitz. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
In summary, Christoph Schuhmacher is a distinguished inventor whose work in cancer diagnostics and therapy is paving the way for new treatment options. His contributions are vital to the ongoing fight against malignant tumors, particularly diffuse gastric carcinoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile